南非西开普省HIV感染儿童、HIV暴露未感染儿童及HIV未暴露未感染儿童的乙型肝炎病毒感染与疫苗覆盖率
本研究利用南非西开普省671名13岁以下儿童的次级数据和存档血清,评估HIV感染儿童(CLWH)、HIV暴露未感染儿童(HEU)和HIV未暴露未感染儿童(HUU)的乙肝疫苗覆盖率和及时接种情况。结果显示三剂疫苗12月龄覆盖率在CLWH为86.7%、HUU为80.9%、HEU为77.0%,HBV感染在HEU为1.4%、HUU为0.3%,CLWH无病例。结论强调HIV暴露儿童及时接种疫苗存在差异,需针对性干预。
要点
- 三剂乙肝疫苗12月龄覆盖率:CLWH 86.7%(13/15)、HUU 80.9%(263/325)、HEU 77.0%(57/74)。
- 第三剂延迟接种比例最高为CLWH 23.1%(3/13),HUU 21.6%(58/269),HEU 15.3%(9/59),p=0.540。
- HBV感染检出率:HEU 1.4%(1/74),HUU 0.3%(1/328),CLWH无病例。
核心结论
- 研究发现HIV暴露儿童在乙肝疫苗及时接种和覆盖率方面存在差异,强调需要针对性干预以确保HIV暴露儿童及时接种疫苗。
研究设计与样本
- 本研究使用来自南非西开普省13岁以下儿童的次级数据和存档血清(N=671),这些儿童在卫生机构就诊。
- 乙肝疫苗覆盖率通过12月龄内第1至3剂接种记录评估,及时接种定义为在推荐年龄前4天至后28天内接种。
- 采用Elecsys®检测试剂盒(罗氏诊断,德国)测量感染和免疫的血清学标志物,并使用逻辑回归分析不完整和延迟接种的相关因素。
主要发现
- 12月龄内三剂疫苗覆盖率:CLWH为86.7%(13/15),HUU为80.9%(263/325),HEU为77.0%(57/74)。
- 随着免疫程序推进,所有亚组的乙肝疫苗覆盖率均下降。
- 第三剂延迟接种比例最高为CLWH 23.1%(3/13),其次为HUU 21.6%(58/269)和HEU 15.3%(9/59),p=0.540。
- 第三剂中位延迟时间CLWH最长(11.3周),HUU为6.7周,p=0.368。
- HBV感染检出率:HEU为1.4%(1/74),HUU为0.3%(1/328),CLWH无病例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Limited evidence on the burden of hepatitis B virus (HBV) infection among children living with HIV (CLWH), HIV-exposed uninfected (HEU) and HIV-unexposed uninfected (HUU) children hinders progress towards eliminating hepatitis B. METHODS: This study used secondary data and archival sera (N = 671) from children <13 years old attending health facilities in the Western Cape, South Africa. Hepatitis B vaccine coverage was assessed using vaccination records for doses 1 to 3 by 12 months of age. Timely uptake was defined as receipt of a dose from 4 days before to 28 days after the recommended age. Serological markers of infection and immunity were measured using Elecsys® test kits (Roche Diagnostics, Germany). Logistic regression was performed to assess factors associated with incomplete and delayed vaccination. RESULTS: Coverage with all three doses by 12 months was 86.7 % (13/15), 80.9 % (263/325), and 77.0 % (57/74) for CLWH, HUU, and HEU, respectively. Hepatitis B vaccine coverage decreased across all subgroups as the schedule progressed. The highest proportion of delayed uptake for the third dose was noted among CLWH at 23.1 % (3/13), followed by 21.6 % (58/269) among HUU and 15.3 % (9/59) among HEU children (p = 0.540). Median delay for dose 3 was longest among CLWH (11.3 weeks) compared to HUU (6.7 weeks) (p = 0.368). HBV infection was detected in 1.4 % (1/74) of HEU and 0.3 % (1/328) of HUU children, with no cases among CLWH. Factors associated with completing the third dose included crèche attendance, lower-middle socio-economic status (SES), timely uptake of dose 1, participant's age, and HIV exposure status. Crèche attendance was associated with a lower likelihood of delayed uptake, while increasing age was associated with a higher likelihood of delay. CONCLUSION: Our findings highlight disparities in timely hepatitis B vaccine uptake and coverage, emphasizing the need for targeted interventions ensuring timely vaccine uptake among HIV-exposed children.
引用
- Collins C, Ratshisusu L, Modise LM, et al. Hepatitis B virus infection and vaccine coverage among children living with HIV, HIV-exposed uninfected, and HIV-unexposed uninfected children in the Western Cape, South Africa. Vaccine. 2025. PMID: 41092803. doi:10.1016/j.vaccine.2025.127843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。